BioSpring GmbH
Fatima Baker is an experienced professional in the field of biological sciences with a strong background in hematology and oncology. Currently serving as an Operational QA-Manager at BioSpring GmbH since March 2022, Fatima previously worked as a Researcher PhD Student at Universitätsklinikum Frankfurt am Main from August 2017 to March 2022, focusing on the role of autophagy in leukemia treatment. Fatima's academic journey includes a Ph.D. from Goethe University Frankfurt, a Master of Science from the University of Konstanz, and a Bachelor of Science also from the University of Konstanz. Earlier roles include research assistant positions and internships at institutions such as Newcastle University and Universidade Estadual Paulista Júlio de Mesquita Filho, where Fatima contributed to various biological research projects.
This person is not in any offices
BioSpring GmbH
BioSpring is a leading industry expert in oligonucleotide science and technology, specializing in high-quality cGMP manufacturing and analytics for commercial programs and clinical phases I-III, in addition to preclinical material supply and diagnostic manufacturing. We are a privately owned company of ~600 employees committed to providing expert support through all phases and regulatory filings, including highly flexible and customizable solutions to accelerate therapeutic programs through the entire drug development lifecycle. Headquartered in the center of Europe, in Frankfurt, Germany, we are an international company with a subsidiary in the United States and a local presence in Japan. Our global clients can rely on our quality and expertise, guided by our passion for innovation and more than 27 years of experience. Our aim is a highly collaborative partnership to unleash the full potential of our clients’ technology – making great strides and breakthroughs possible. We are driven by our desire for a healthier world. Restoring hope in patients living with debilitating diseases is our daily motivation to progress novel nucleic acid-based therapies to their commercial promise. Privacy notice: https://www.biospring.de/datenschutz-socialmedia/